Benzinga
29 Jun 2026, 06:34 UTC · 1h ago
Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Benzinga
29 Jun 2026, 06:34 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Viridian Therapeutics Inc. (VRDN) received FDA approval and launched Lumvoa for the treatment of thyroid eye disease. — FDA approval and commercial launch of a new drug is a major catalyst for revenue growth and valuation in biotech.
+0.60Lantheus Holdings Inc. (LNTH) received a Complete Response Letter (CRL) from the FDA regarding its new drug application for LNTH-2501. — A CRL indicates the FDA will not approve the application in its current form, delaying potential product launches and revenue.
-0.50Universe Pharmaceuticals Inc. (UPC) will acquire Best Praise International for $10.75 million. — Strategic acquisitions generally signal growth, though the impact depends on the synergy and scale relative to the company.
+0.30Continue reading
6 related stories
Top 2 movers · tap to explore
Concentrix Corp. (CNXC) and AeroVironment Inc. (AVAV) are scheduled to report quarterly earnings after the closing bell. — Earnings reports create short-term volatility, though the impact is neutral until the actual numbers are released.
+0.20Which stocks this story touches
Shares jumped 10.7% following FDA approval and launch of Lumvoa.
The FDA issued a Complete Response Letter regarding a new drug application, indicating a setback.
Shares jumped 11% on Friday ahead of quarterly earnings expectations.
Shares gained 4.2% following the announcement of an acquisition of Best Praise International.
Shares gained 0.9% on Friday heading into their earnings release.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Benzinga
2h ago
